Random urine samples were collected from 305 children aged from birth to 14 years and the values of hydroxymethoxymandelic acid, homovanillic acid, noradrenaline, adrenaline, and dopamine were measured by high-performance liquid chromatography with electrochemical detection. The results were reported relative to the urinary creatinine concentration and the values declined progressively with increasing age for each analyte with the exception of adrenaline. The results for each age group were not normally distributed and all values except outliers were retained in determining the upper reference limits.
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In children, the urinary excretion of biogenic amines and their metabolites increases with agel but when these values are related to the urinary creatinine excretion the relative values decrease.P Changing reference values are particularly important in the diagnosis of tumours such as neuroblastoma, 750/0 of which occur before the age of 4 years. The validity and convenience of random urine samples for these analytes has been accepted.v? Relating excretion to urinary creatinine which is produced at a constant rate minimizes the differences in children of similar ages due to size or sex," although this is controversial." Taking daytime samples minimizes the influence of diurnal variation. 1 In neuroectodermal tumours, the pattern of urinary excretion of amines and their metabolites varies widely and dopamine as well as the adrenaline and noradrenaline pathways should be assessed to maximize the sensitivity of the biochemical test. 8.9 Recently reported data from the European Neuroblastoma Study Group concluded that the screening of infants using urinary hydroxymethoxymandelic acid (HMMA) and homovanillic acid (HV A) Correspondence: Dr W P Tormey, Department of Chemical Pathology, Beaumont Hospital, Dublin 9, Ireland. 400 alone will miss 30-40% of stage I and II tumours and about 20% of stage III tumours.'?
The widely differing published reference values for the excretion of catecholamines and their metabolites reflect the diversity of analytical methods and data manipulations used. Reports from the United Kingdom External Quality Assessment Scheme (UKEQAS) for urinary catecholamines confirm the continuing large variation in laboratory analytical performance. With increasing interest in screening programmes aimed at improving the detection rate of neuroblastoma, and hopefully the prognosis, the importance of establishing detailed reference ranges cannot be overstated. Thus we report our age and creatinine related upper reference limits for urinary adrenaline, noradrenaline, dopamine, HMMA, and HVA using high-performance liquid chromatography (HPLC) with electrochemical (EC) detection.
MATERIALS AND METHODS
Random urine samples were collected from 305 well children. These included 198 attending orthopaedic outpatient clinics, 44 from a general practice age register, 33 from neonatal and 6 week post partum routine hospital baby checks and 30 from a daycare nursery. All specimens were collected during the normal working day.
The urines were collected into universal containers pretreated with O' 5 mL 500lo HCI except in neonates and in those children who were not toilet trained where sterile disposable paediatric urine container bags were used. These were not preacidified but the urines were transferred to an acidified container immediately after collection. Samples were stored at -20°C and analysed in batches.
Urinary free catecholamines were determined by HPLC with electrochemical detection using the method of Davidson and Fitzpatrick!' without modification. Low sample volumes or technical difficulties were responsible for the differences in the number of results for some age groups. For example, shortage of sample prevented dilution and reanalysis of some concentrated urines with very high dopamine values which had exceeded the detector scale. Some low adrenaline values were lost because of a deterioration in the sensitivity of the assay for this analyte as indicated by internal control procedures. This was partly related to the recycling of the mobile phase, found necessary due to cost. Urinary HMMA and HVA were assayed by HPLC and EC detection using a minor modification of Davidson's method.'! The sample volume was reduced from 1 mL spiked with 100 /-lL of standard to O' 5 mL spiked with 50/-lL of standard to enable assay of small samples.
The HPLC system consisted of a Waters 600E solvent delivery system (Waters Associates, Milford, MA, USA) with a Waters 712 automatic sampler. The electrochemical detector was a Waters 460 with a glassy carbon electrode, set at + 0·8 V which gave maximum sensitivity for the metabolic compounds. The detector output was converted from analogue to digital by means of a Waters detector interface module and processed using the Waters 'Maxima' data handling package.
Precision
Using commercially available control urine (n = 15 at each level), the within batch coefficients of variation (CVs) were, respectively, 9· SOlo at 21/-lmollL and 4· 90lo at 82/-lmollL for HMMA, 7· 100o at 14 /-lmollL and 5· OOlo at 80 /-lmollL for HVA, 4· 40lo at O·248 /-lmol/L and 8'1 Olo at O·998 /-lmol/L for noradrenaline, 9· 3Olo at O·073 /-lmol/L and 3· 40lo at O' 292/-lmol/L for adrenaline, and 2· 80lo at 0'780 J.Llllol/L and 3 '40lo at 2'678/-lmol/L for dopamine. The between batch CVs, calculated over 30 consecutive procedures in a 12 month period were 15· OOlo at 20 JLmol/L and 6' 3Olo at 80 JLmol/L for HMMA, 18· 70lo at 16/-lmol/L and 7· SOlo at 80 /-lmol/L for HVA, 8·5 Olo at O' 234 JLmol/L and 8· 90lo at O'996/-lmol/L for noradrenaline and 7· 40lo at O'698 /-lmol/L and 10' 3Olo at 2· 549 JLmol/L for dopamine. These figures are slightly better than those obtained by the original authors for noradrenaline, dopamine!' and HVA 12 and slightly worse than for HMMA.12 Between batch CVs for adrenaline were 28· 2Olo at O·068 /-lmollL and 9'20lo at 0'330 /-lmol/L calculated from 24 assay procedures. The original between batch coefficient of variation for adrenaline by this method was 12· 90lo at a level above the reference range, which is higher than our value.II No figure was published for a lower value within the reference range and our experience indicates very poor precision at such levels. A column change and renewals of the mobile phase were carried out during the study period. The results were unaffected by the changes.
Recovery
Forty urines spiked with aqueous standard were used to determine recovery. The values for HMMA and HVA at 110 JLmol/L, noradrenaline at O' 295/-lmol/L, adrenaline at 0'115/-lmollL, and dopamine at O'325 /-lmol/L were 93Olo, 98Olo , 920lo, 950lo and 880lo, respectively. Linearity HMMA and HVA were linear to at least 220 and 180/-lmol/L, respectively. Noradrenaline was linear up to 2· 0 J.Llllol/L, adrenaline to 2' 6 J.Llllol/L and dopamine to 3· 0 /-lmol/L. Samples for urinary creatinine were diluted 1 in 10 and analysed on a Hitachi 704 (Boehringer Mannheim, Dublin, Ireland) using the Jaffe reaction without deproteinization.
RESULTS
Results are shown in Figs 1 to 5 for each group with reference to the urinary creatinine and are not normally distributed. The difficulty of obtaining sufficient numbers for statistical calculation of reference limits is a perennial problem in paediatrics, especially when stratification into several age groups is required. For example, at least 120 values are needed for reliable estimation of the o·975 fractile." Since none of the age groups in this study reach this number, the suggested upper limits are based on the range of data values after elimination of outliers by visual inspection of the distributions and are displayed in Figs 1 to 5. The broken line border represents the suggested upper limits and the extreme values would also have been excluded by the Dixon range statistic. I] (A possible outlier is rejected if the distance between it and its nearest neighbour is greater than one-third of the range.) Despite an apparent age-related trend in urinary adrenaline excretion, the scatter of values is such that we suggest that an arbitrary upper limit of 0'08 mmol adrenaline/mol creatinine be used ( Fig. 4 ) but clearly further refinement of this limit is needed. 
DISCUSSION
The importance of establishing reliable reference ranges for catecholamines and their metabolites is highlighted by the possible improvement in prognosis for neuroblastoma with early detection. 14 .;. Soldin and Hill listed HMMA and HVA values on random urine samples from birth to. 20 years. IS Their ranges for children less than 1 year old were very high but the l00th percentile values for the rest of their groups were broadly similar to ours. Another paper using HPLC studied children of 3 years and older and reported HMMA and HV A values about 50070 lower than ours.'? In their discussion the authors acknowledged that younger children should also be studied because of the incidence of neuroblastoma in early life. Internal standard was omitted in their HMMA method but not in the method for catecholamines. Dale et al. used gas chromatography with flame ionization detection and filter paper samples suitable for mass screening.P Data on 808 infants aged 6 months were log transformed to a normal distribution because of a slight skew and the transformed mean HMMA value was 6·8 ILmol/mmol creatinine with an upper 95070 confidence interval limit of 15 ILmol/mmol. The mean HVA value was 10· 9 ILmol/mmol creatinine with an upper 95070 limit of 25' 5 JLmol/mmol. The HV A values were similar to ours but the HMMA values were about 50070 higher. Their method was reported linear to 16·0 JLmol/L for both HVA and HMMA, which is adequate for that age group. By contrast Walters et al. 2 found a skewed distribution of values which were not normalized by logarithmic or square root transformation and reported their data in a similar manner to that used here.
Describing the previously published data on catecholamine excretion in healthy children as 'scanty and incomplete', Parra et al. 21 themselves using small numbers found that catecholamine excretion per gram of urinary creatinine decreased with age. Their values were considerably lower than ours and they used Gaussian statistics ignoring the obvous skew in their data. They favoured expressing their results in relation to body surface area, like De Schaepdryver et al., 22 but the latter found no consistent change in the excretion of catecholamines or their metabolites with increasing size. Using HPLC methods, Rosano-' also found that the excretion of adrenaline, noradrenaline and dopamine decreased with age and quoted reference values considerably lower than ours but higher than those of Premel-Cabic et al. 19 Pediatric reference ranges for catecholamines based on 24 h collections were determined by Moyer et al. 24 but were not related to urinary creatinine. The recently published data by Reed et al. 2 5 using Gaussian statistics for adrenaline, noradrenaline and dopamine excretion in relation to urinary creatinine were respectively only about 10070, 25070 and 50070 of our range. But Henderson et al. 26 reported dopamine and HV A values very similar to ours with HMMA levels considerably higher only in their youngest subjects. However, some of these babies were ill inpatients.
Our performance in the UKEQAS for urinary catecholamines has been close to the method mean for each analyte. Thus our reference data may be used by any laboratory with good analytical methods which has shown satisfactory performance in external quality assessment schemes for catecholamines and their metabolites.
